I guess we will see if the expert opinion is positive by Clinuvel's next steps. My guess is that further trials will not be progressed as there is not enough of an efficacy signal to justify further investment. Clinuvel will not announce this. They will instead announce that progress will be determined following discussions with regulators and securing IP which will always be about to happen. VP ( 4 years), vitiligo (10 years), 6th indication (18 months), OTC (3 years) all waiting for something.
Ann: Positive Final Results in Stroke Study CUV801, page-26
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.28 |
Change
-0.250(1.85%) |
Mkt cap ! $664.8M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.62 | $13.25 | $1.157M | 86.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $13.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.42 | 228 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |